NCT02850341

Brief Summary

The purpose of this study is to determine if the use of pedometers can help depressive inpatients in psychiatric clinics to increase their level of physical activity. Therefore patients are given a pedometer and instructions how to raise their level of daily steps. Intervention group is compared with a control group that is receiving treatment-as-usual. The intervention is hypothesized to increase number of daily steps and have positive effects on mood, depression and anxiety.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
292

participants targeted

Target at P75+ for not_applicable depression

Timeline
Completed

Started Jul 2016

Typical duration for not_applicable depression

Geographic Reach
2 countries

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

July 22, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 1, 2016

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

September 1, 2021

Status Verified

August 1, 2021

Enrollment Period

3.5 years

First QC Date

July 22, 2016

Last Update Submit

August 27, 2021

Conditions

Keywords

Physical ActivityMental HealthHealth BehaviorWalkingPhysical ExerciseMental disorder

Outcome Measures

Primary Outcomes (2)

  • Change in average number of steps per day

    Number of steps per day is objectively measured using accelerometry (ActiGraph GT1M)

    From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)

  • Change in depressive symptoms - clinician rated

    Depressive symptoms are rated by a blind study employee using MADRS

    From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)

Secondary Outcomes (13)

  • Change in physical activity - subjective

    From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)

  • Change in physical activity - objective

    From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)

  • Change in psychopathological symptoms

    From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)

  • Change in health-related quality of life

    From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)

  • Change in depressive symptoms

    From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)

  • +8 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Patients receive a pedometer and instructions how to raise their physical activity

Device: Pedometer

Control group

NO INTERVENTION

Patients receive treatment-as-usual

Interventions

PedometerDEVICE

Patients receive a pedometer with instructions how to raise their number of daily steps

Intervention group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Major Depression, moderate to severe as main diagnosis
  • Inpatient status
  • Prospected inpatient treatment of at least 4 weeks
  • Able to understand german

You may not qualify if:

  • Physical disease or disability that makes it impossible to reach the goal 5000 steps per day
  • Borderline personality disorder
  • Bipolar Disorder
  • Schizophrenia
  • Anorexia Nervosa
  • Dementia
  • Psychotic Depression
  • Pregnancy
  • Acute suicidality
  • Substance dependancies with actual consumption (except nicotine)
  • Current pedometer-use
  • More than 10.000 steps per day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Paracelsus University Salzburg - Clinic for Psychiatry and Psychotherapy

Salzburg, 5020, Austria

Location

Ludwig Maximilian University Munich - Clinic for Psychiatry and Psychotherapy

Munich, Bavaria, 80366, Germany

Location

Oberhavel Clinics GmbH - Clinic for Psychiatry, Psychosomatics and Psychotherapy

Hennigsdorf, Brandenburg, 16761, Germany

Location

Health Center Odenwaldkreis GmbH - Center for Mental Health

Erbach im Odenwald, Hesse, 64711, Germany

Location

University of Frankfurt/Main - Clinic for Psychiatry, Psychosomatic and Psychotherapy

Frankfurt am Main, Hesse, 60528, Germany

Location

University of Göttingen - Clinic for Psychiatry and Psychotherapy

Göttingen, Lower Saxony, 37075, Germany

Location

University RWTH Aachen, Clinic for Psychiatriy, Psychotherapy and Psychosomatic

Aachen, North Rhine-Westphalia, 52074, Germany

Location

Ev.Luth. Diakonissenanstalt Flensburg - Clinic for Psychiatry, Psychosomatic and Psychotherapy

Flensburg, Schleswig-Holstein, 24939, Germany

Location

Charité Universitätsmedizin Berlin - Departement of Psychiatry

Berlin, 10117, Germany

Location

Related Links

MeSH Terms

Conditions

DepressionMotor ActivityPsychological Well-BeingHealth BehaviorMental Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorPersonal Satisfaction

Study Officials

  • Andreas Ströhle, Prof.Dr.

    Charité Universitätsmedizin Berlin - Klinik für Psychiatrie und Psychotherapie

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med.

Study Record Dates

First Submitted

July 22, 2016

First Posted

August 1, 2016

Study Start

July 1, 2016

Primary Completion

January 1, 2020

Study Completion

January 1, 2020

Last Updated

September 1, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations